← All trials
NCT03254186
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 18, 2017
- Primary completion
- Feb 1, 2019
- Completion date
- Feb 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 15
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Emory UniversityLead sponsor
- Emory UniversityReponsible party - principal investigator
- Emory UniversityOverall official - principal investigator
- Atlanta Clinical and Translational Science InstituteCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.